Safety and Efficacy of amplitude-modulated radiofrequency electromagnetic fields in advanced hepatocellular carcinoma

All issues

Volume 4 (2021)

4open, 4 (2021) 3

Full HTML

Open Access

Figure 1

Download original image

Survival curves of patients receiving treatment with the TheraBionic device. OS of 59 patients treated with the TheraBionic device stratified by Child-Pugh status (A/B/C).